PARK MEDI WORLD IPO

DATEGMP (GREY MARKET PREMIUM)EXPECTED LISTING GAINS
12-Dec-20256552
11-Dec-2025131,196
10-Dec-2025262,392

Park Medi World IPO Overview

The Park Medi World IPO comes from a healthcare chain offering diagnostic services, pharmacy operations, and medical centres across multiple locations. The company aims to enhance accessible healthcare by integrating retail and diagnostic capabilities, serving a growing population in both urban and semi-urban regions. With the Indian healthcare sector undergoing rapid expansion, the IPO has drawn attention from investors tracking long-term healthcare themes.

The Park Medi World IPO GMP is active in the market, showing early interest.

Important Dates

(Only confirmed dates included)

  • IPO Opening Date: 10 December 2025
  • IPO Closing Date: 12 December 2025

Park Medi World IPO Price & Issue Size

  • Price Band: ₹154 to ₹162 per share
  • Total Issue Size: Approximately ₹920 crore

These values indicate a significantly larger offering compared to typical SME issues, positioning Park Medi World as a major healthcare listing with substantial fundraising objectives.

Lot Size

92 shares.

Company Background

Park Medi World focuses on multi-service healthcare delivery through pharmacies, diagnostic labs, and walk-in medical centres. The company aims to make healthcare more accessible and reduce patient turnaround time by combining testing and medicine procurement under one roof. With increasing healthcare needs, the company is expanding its operational footprint.

Its model allows cross-utilization of customers between diagnostic and retail pharmacy operations, enhancing revenue visibility. As lifestyle diseases rise and preventive testing grows, companies like Park Medi World are positioned to serve long-term demand.

Objects of the Issue

Although a detailed RHP breakdown is not yet public, typical usage for a healthcare IPO of this scale includes:

  • Expansion of new diagnostic centres
  • Setting up additional pharmacies
  • Upgrading medical and diagnostic equipment
  • Strengthening working capital
  • General corporate activities

Strengths

  • Operating in a high-growth healthcare sector
  • Integrated model combining retail pharmacy and diagnostics
  • Strong demand for preventive and regular medical testing
  • Increasing reach into tier-2 and tier-3 cities

Risks

  • High competition from regional and national healthcare chains
  • Regulatory oversight and compliance burden
  • Price-sensitive pharmacy market affecting margins